Ken Griffin Graybug Vision, Inc. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.46 - $1.05 $230 - $525
500 New
500 $0

Others Institutions Holding GRAY

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GRAYBUG VISION, INC.

GRAY Quotes by TradingView
  • Ticker GRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,517,700
  • Market Cap $63.5M
  • Description
  • Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...
More about GRAY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email